BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18463014)

  • 1. Melanoma recurrence confined to a free flap after isolated limb perfusion.
    Roberts CE; Harris PA; Thomas JM
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):e277-9. PubMed ID: 18463014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases.
    Pace M; Gattai R; Mascitelli EM; Millanta L
    J Surg Oncol; 2011 Dec; 104(7):718-23. PubMed ID: 21721008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional isolated perfusion: also applicable in elderly patients].
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
    Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness.
    van Akkooi AC; Golab-Schwarz HD; Eggermont AM; van Geel AN
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):408-10. PubMed ID: 16829108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.
    Klaase JM; Kroon BB; van Geel AN; van Wijk J; Franklin HR; Eggermont AM; Hart AA
    J Am Coll Surg; 1994 Jun; 178(6):564-72. PubMed ID: 8193749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF dose reduction in isolated limb perfusion.
    Grünhagen DJ; de Wilt JH; van Geel AN; Graveland WJ; Verhoef C; Eggermont AM
    Eur J Surg Oncol; 2005 Nov; 31(9):1011-9. PubMed ID: 16099618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.